Lopetuso LR - Search Results

1

The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.

Lopetuso LR, Scaldaferri F, Bruno G, Petito V, Franceschi F, Gasbarrini A. Lopetuso LR, et al. Eur Rev Med Pharmacol Sci. 2015;19(6):1068-76. Eur Rev Med Pharmacol Sci. 2015. PMID: 25855934 Free article. Review.

2

The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide.

Forte E, Pizzoferrato M, Lopetuso L, Scaldaferri F. Forte E, et al. Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):25-37. Eur Rev Med Pharmacol Sci. 2012. PMID: 22338545 Review.

3

The gut barrier: new acquisitions and therapeutic approaches.

Scaldaferri F, Pizzoferrato M, Gerardi V, Lopetuso L, Gasbarrini A. Scaldaferri F, et al. J Clin Gastroenterol. 2012 Oct;46 Suppl:S12-7. doi: 10.1097/MCG.0b013e31826ae849. J Clin Gastroenterol. 2012. PMID: 22955350 Review.

4

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.

Lopetuso LR, Scaldaferri F, Pizarro TT. Lopetuso LR, et al. Fibrogenesis Tissue Repair. 2012 Oct 14;5(1):18. doi: 10.1186/1755-1536-5-18. Fibrogenesis Tissue Repair. 2012. PMID: 23062310 Free PMC article.

5

Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.

Scaldaferri F, Petito V, Lopetuso L, Bruno G, Gerardi V, Ianiro G, Sgambato A, Gasbarrini A, Cammarota G. Scaldaferri F, et al. Mediators Inflamm. 2013;2013:391473. doi: 10.1155/2013/391473. Epub 2013 May 8. Mediators Inflamm. 2013. PMID: 23737647 Free PMC article. Review.

6

Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.

Lopetuso LR, Petito V, Cufino V, Arena V, Stigliano E, Gerardi V, Gaetani E, Poscia A, Amato A, Cammarota G, Papa A, Sgambato A, Gasbarrini A, Scaldaferri F. Lopetuso LR, et al. Dig Liver Dis. 2013 Dec;45(12):1017-21. doi: 10.1016/j.dld.2013.06.007. Epub 2013 Aug 2. Dig Liver Dis. 2013. PMID: 23911613

7

Commensal Clostridia: leading players in the maintenance of gut homeostasis.

Lopetuso LR, Scaldaferri F, Petito V, Gasbarrini A. Lopetuso LR, et al. Gut Pathog. 2013 Aug 13;5(1):23. doi: 10.1186/1757-4749-5-23. Gut Pathog. 2013. PMID: 23941657 Free PMC article.

8

Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.

Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, Bruno G, Petito V, Laterza L, Cammarota G, Gaetani E, Sgambato A, Gasbarrini A. Scaldaferri F, et al. Among authors: lopetuso lr. Biomed Res Int. 2013;2013:435268. doi: 10.1155/2013/435268. Epub 2013 Aug 7. Biomed Res Int. 2013. PMID: 23991417 Free PMC article. Review.

9

Role of yeasts in healthy and impaired gut microbiota: the gut mycome.

Ianiro G, Bruno G, Lopetuso L, Beghella FB, Laterza L, D'Aversa F, Gigante G, Cammarota G, Gasbarrini A. Ianiro G, et al. Curr Pharm Des. 2014;20(28):4565-9. doi: 10.2174/13816128113196660723. Curr Pharm Des. 2014. PMID: 24180411 Review.

10

Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?

Scaldaferri F, Petito V, Papa A, Cesarini M, Arena V, Lopetuso LR, Corbi M, Perino F, Caldarola G, Carbone A, Corazziari E, Sgambato A, Gasbarrini A, De Simone C. Scaldaferri F, et al. Among authors: lopetuso lr. Gut. 2014 Apr;63(4):699-701. doi: 10.1136/gutjnl-2013-305478. Epub 2013 Nov 19. Gut. 2014. PMID: 24253935 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page